AstraZeneca plans to shutter lab, ax staffers

AstraZeneca ($AZN) is shuttering a lab in Devon, U.K., saying that it will now outsource work done to test the environment impact of drugs. The pharma giant has been undergoing a major restructuring, its third reorganization in recent years. The lab employs 71 people. An AstraZeneca exec says they plan to "support" the workers in coming months and would prefer to see the facility remain open. Release